APA (7th ed.) Citation

Burkhardt, J., Shin, B. J., Schlaff, C. D., Riina, H., & Boockvar, J. A. (2011). Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme. Journal of Experimental Therapeutics & Oncology, 9(3), 183.

Chicago Style (17th ed.) Citation

Burkhardt, Jan-Karl, Benjamin J. Shin, Cody D. Schlaff, Howard Riina, and John A. Boockvar. "Cost Analysis of Intra-arterial Versus Intra-venous Delivery of Bevacizumab for the Treatment of Recurrent Glioblastoma Multiforme." Journal of Experimental Therapeutics & Oncology 9, no. 3 (2011): 183.

MLA (9th ed.) Citation

Burkhardt, Jan-Karl, et al. "Cost Analysis of Intra-arterial Versus Intra-venous Delivery of Bevacizumab for the Treatment of Recurrent Glioblastoma Multiforme." Journal of Experimental Therapeutics & Oncology, vol. 9, no. 3, 2011, p. 183.